UBE2V2 Human

Ubiquitin-Conjugating Enzyme E2 Variant 2 Human Recombinant
Cat. No.
BT19626
Source
Escherichia Coli.
Synonyms
DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2, Ubiquitin-conjugating enzyme E2 variant 2, Enterocyte differentiation-associated factor 1, Enterocyte differentiation-promoting factor 1, Vitamin D3-inducible protein, UBE2V2.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

UBE2V2 Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 165 amino acids (1-145 a.a.) and having a molecular mass of 18.5 kDa. The UBE2V2 is fused to 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
UBE2V2 is a distinct subfamily within the E2 protein family. Although similar in sequence to other ubiquitin-conjugating enzymes, it lacks the conserved cysteine residue crucial for typical E2 catalytic activity. Homologous to ubiquitin-conjugating enzyme E2 variant 1 and the yeast MMS2 gene product, UBE2V2 plays a role in monocyte and enterocyte differentiation.
Description
Recombinant Human UBE2V2, expressed in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 165 amino acids (with a sequence spanning residues 1-145) and has a molecular weight of 18.5 kDa. For purification purposes, a 20 amino acid His-Tag is fused to the N-terminus. The protein is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
UBE2V2 Human is supplied in a solution buffered with 20mM Tris (pH 8.0) and containing 0.1M NaCl and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be kept at 4°C. For extended storage, freezing at -20°C is recommended. Adding a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freeze-thaw cycles should be avoided.
Purity
Purity is determined to be greater than 95.0% using SDS-PAGE analysis.
Synonyms
DDVit-1, DDVIT1, EDAF-1, EDPF-1, EDPF1, MMS2, UEV-2, UEV2, Ubiquitin-conjugating enzyme E2 variant 2, Enterocyte differentiation-associated factor 1, Enterocyte differentiation-promoting factor 1, Vitamin D3-inducible protein, UBE2V2.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MAVSTGVKVP RNFRLLEELE EGQKGVGDGT VSWGLEDDED MTLTRWTGMI IGPPRTNYEN RIYSLKVECG PKYPEAPPSV RFVTKINMNG INNSSGMVDA RSIPVLAKWQ NSYSIKVVLQ ELRRLMMSKE NMKLPQPPEG QTYNN.

Product Science Overview

Introduction

Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2) is a crucial component of the ubiquitin-proteasome system (UPS), which is responsible for the regulation of protein degradation in eukaryotic cells. This enzyme plays a significant role in various cellular processes, including DNA repair, cell cycle regulation, and signal transduction.

Structure and Function

UBE2V2, also known as UEV2, is a member of the E2 ubiquitin-conjugating enzyme family. Unlike other E2 enzymes, UBE2V2 does not have ubiquitin ligase activity on its own. Instead, it forms a heterodimer with UBE2N (Ubc13), another E2 enzyme. This heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through lysine 63 (Lys-63). These Lys-63-linked poly-ubiquitin chains do not target proteins for degradation by the proteasome but are involved in signaling pathways, such as DNA damage response and NF-κB activation .

Biological Significance

The UBE2V2/UBE2N heterodimer is essential for various cellular functions. It mediates the transcriptional activation of target genes and plays a critical role in the DNA damage response. The formation of Lys-63-linked poly-ubiquitin chains by UBE2V2/UBE2N is crucial for the recruitment of DNA repair proteins to sites of damage, thereby facilitating the repair process .

Clinical Implications

Mutations or dysregulation of UBE2V2 have been implicated in several diseases, including cancer and neurodegenerative disorders. For instance, alterations in the ubiquitination process can lead to the accumulation of damaged or misfolded proteins, contributing to the pathogenesis of these diseases. Understanding the role of UBE2V2 in these processes can provide insights into potential therapeutic targets for treating such conditions .

Research and Applications

Recombinant human UBE2V2 is widely used in research to study its function and interactions with other proteins. By using recombinant proteins, researchers can investigate the molecular mechanisms underlying ubiquitination and its role in various cellular processes. Additionally, recombinant UBE2V2 can be utilized in drug discovery efforts to identify compounds that modulate its activity, offering potential therapeutic benefits .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.